Ildong Pharmaceutical starts Phase 1 study of new diabetes therapy in Germany
Phase 1 study approved for new drug candidate IDG16177, planned to be completed by 2022 SEOUL, South Korea, July 1, 2021 /PRNewswire/ -- A Phase 1 study on new drug candidate IDG16177 of novel oral t...